Decreased bone mineral density (BMD) has been documented in adults with Cushing disease (CD), and allelic variants of the vitamin D receptor (VDR) gene have been associated with osteopenia. Genetic factors play an important role in bone accrual and its response to various diseases; among them, the most studied are the allelic variants of the VDR gene. There is debate as to whether described variants in the VDR gene have an effect on BMD. In the current study, we sought to analyze whether BMD differences in patients with CD were associated with the Taq1 and Apa1 VDR allelotypes. The data showed lack of association between BMD and these widely studied VDR polymorphisms, suggesting that the effect of endogenous hypercortisolism on bone in the context of CD does not depend on VDR genotypes.
Introduction
Adults and children with Cushing disease (CD) have decreased bone mineral density (BMD) (1) . Allelic variants of the vitamin D receptor (VDR) gene have been associated with predisposition to low BMD (2, 3) . We previously investigated the Taq1 and Apa1 VDR alleles for an association with low BMD in women with depression (4) . We recently published an analysis of BMD data at the spine and hip before and after transphenoidal surgery in children with CD, in which we demonstrated that BMD differences within this population were independent of the degree or duration of hypercortisolism (1) . In the current study, we sought to analyze whether differences in BMD in these patients was associated with the Taq1 and Apa1 VDR allelotypes.
Subjects and methods
Subjects were all patients admitted to the NIH Warren Magnuson Clinical Center in the last 10 years. Studies were performed under clinical protocol 97-CH0076, which was approved by the National Institute of Child Health and Human Development (NICHD) Institutional Review Board. Informed consent from the patients ' parents (and assent from older children) was obtained for all patients. Although 35 patients were included in the original analysis of BMD in CD, DNA was available from only 25 patients.
Hologic Inc (Bedford, MA, USA) dual-energy X-ray absorptiometry (DXA) scans were obtained in all children with CD and were retrospectively analyzed. DXA scans were performed on the Hologic densitometers QDR2000, QDR4500, and DelphiA. From the measurement of an anthropomorphic spine phantom, the coeffi cient of variation for determination with the QDR2000 instrument was < 0.5 % , and for the QDR4500 and DelphiA instruments, the values were < 0.4 % for 6 months. Comparison of a spine phantom scanned on both the QDR2000 and QDR4500 instruments and another phantom on both the QDR4500 and Delphi instruments gave BMD determinations that were within 1.0 % . Femoral neck (FN) and lumbar spine (LS) Z-scores were calculated using the NICHD Children ' s Reference Database, which provides age, race, and sex specifi c reference curves, as reported previously (1) ; low bone density for chronological age was defi ned as a Z ≤ -2.00. Our cohort of CD patients included those with short stature secondary to hypercortisolemia. As BMD calculations may be underestimated in shorter patients, we therefore normalized the BMD to a derived reference volume by correcting BMD values to adjust for differences in bone size using bone mineral apparent density (BMAD), an estimation of volumetric bone mass (g/cm 3 ) (1) . BMAD for FN and LS anteriorposterior 2 -4 were calculated, as previously described. Z-scores for BMAD were calculated using the Stanford University Bone Mineral Density website ( http://www-stat-class.stanford.edu/pediatricbones/#applet ).
Peripheral DNA was extracted from patients as previously described (4) . DNA samples were genotyped for the VDR polymorphisms Taq1 (23 patients) and Apa1 (25 patients) by restriction fragment length polymorphism analysis; polymerase chain reaction amplifi cation was performed with published oligonucleotide primers and conditions with subsequent restriction endonuclease digestion and electrophoresis as previously described (4) .
Statistical analysis
Patients were sorted into two groups for each polymorphism, one corresponding to those patients homozygous or heterozygous for the presence of a VDR restriction site and the other consisting of patients lacking a restriction site. Statistical analysis was performed using paired t-tests or its nonparametric parallel (Wilcoxon signed rank test) to compare paired continuous data. Data are presented as mean ± standard deviation (SD) and were analyzed using SAS system software version 9.1 (SAS Institute, Cary, NC, USA). A two-sided p-value of ≤ 0.05 was considered statistically signifi cant.
Results
Baseline demographic and clinical characteristics are presented in Table 1 . BMD data in patients with CD were grouped according to their VDR polymorphism ( Table 2 ). There were no signifi cant differences in BMD Z-scores for patients either homozygous or heterozygous for the presence of the two studied VDR polymorphisms ( Table 2 ).
Discussion
We recently described our cohort of children with CD and their BMD data (1) . In this study, we studied a subset of these patients with CD (from whom DNA was available) for their VDR genotypes using widely studied VDR gene polymorphisms. As maximal bone mass accumulation occurs during childhood, we hypothesized that the VDR genotype would infl uence the degree endogenous hypercortisolism affects BMD. In our study population, there appeared to be no such infl uence. However, given the rarity of the disease, our study was underpowered to detect a difference as small as we observed. With the number of patients included in our study, we would need to observe a difference of approximately 1.25 SDs in BMD for each of the outcomes listed in Table 1 to achieve statistical signifi cance at a two-sided α level of 0.05 and a power of 80 % . One limitation of our analysis is the small sample size. Our results represent a small pilot study; a larger case-control study would be a more ideal approach to study the relationship between BMD and VDR genotypes.
Previous studies in adults with CD have shown variable results with respect to a relationship between measures of hypercortisolemia and BMD Z-scores. In some studies, BMD Z-scores were negatively correlated with cortisol levels (5, 6) . Our data in pediatric patients showed no correlations of degree of osteopenia with cortisol levels or length of disease (1) . Similarly, adults with depression and hypercortisolism had a BMD effect that depended on VDR genotype, whereas in this study children with CD did not. Is it possible that VDR effects in children are different ? Or is it that CD and/or hypercortisolism in children affect bone differently ? These are questions that this limited study could not answer. It is also possible that other genes may contribute to variations in BMD in CD patients that we did not investigate, including collagen type I α 1 (COL1A1) and estrogen receptor polymorphisms. 
